AI Article Synopsis
- Sleeve gastrectomy (SG) is a popular weight-loss surgery that may help reduce obesity-related health issues, with the antral resection's distance from the pylorus potentially impacting GERD outcomes.
- A study of 220 patients divided them into two groups based on the starting point of antral resection (2 cm vs. 4 cm from the pylorus) and assessed GERD symptoms after 12 months using the GerdQ questionnaire.
- Results showed no significant difference in weight loss or new GERD cases between the two groups, indicating that the specific start point for antral resection may not affect these outcomes.
Article Abstract
Purpose: Sleeve gastrectomy (SG) has gained worldwide popularity by surgeons due to acceptable results in weight loss and obesity-associated medical problems. Distance from the pylorus during antral resection in SG may be effective in decreasing the occurrence of gastroesophageal reflux disease (GERD). The aim of this study was to evaluate GERD symptoms and weight loss outcomes in two groups of SG patients with different start points of antral resection.
Methods: This is a prospective cohort study on 220 patients who underwent SG between June 2019 and July 2021, aged 18 and above, BMI ≥ 40 kg/m, or BMI > 35 kg/m with at least one obesity-associated medical problem. According to the start point of antral resection the patients were divided in two groups (group A: from 2 cm of pylorus and group B: from 4 cm of pylorus). Evaluation of GERD was performed using GerdQ questionnaire at 12-month follow up.
Results: Mean age and BMI of all patients were 37.6 ± 10 year and 44.8 ± 5.7 kg/m at the time of SG. Totally 153(69.5%) of the patients were female. De novo GERD after 12 months in the groups A and B was found in 18 (20%) and 19 (21%) patients. TWL% at 12-month follow ups, were 33.9% and 32.5% in group A and B, respectively.
Conclusion: Antral resection's start point has no statistically significant effect on the excess and total weight loss indices, resolution of the obesity-related medical problems and De novo GERD between 2 and 4 cm start point for antral resection during SG.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00464-023-10011-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sleeve gastrectomy with antral resection provides more effective weight loss in patients with super obesity.
Langenbecks Arch Surg
January 2025
Faculty of Medicine Training and Research Hospital, Department of Gastrointestinal Surgery, Sakarya University, Sakarya, Turkey.
Background: Obesity is a growing health issue that contributes to numerous diseases and lowers quality of life. In patients with super obesity (BMI > 50 kg/m²), bariatric surgery, particularly laparoscopic sleeve gastrectomy (LSG), is a common treatment option. However, the role of antral resection (AR) in LSG remains unclear, especially in this high-risk population.
View Article and Find Full Text PDFBackground: This study aimed to compare outcomes following antral preserving (AP) and antral resecting (AR) laparoscopic sleeve gastrectomy (LSG) in terms of weight loss, gastric emptying time, gastroesophageal reflux disease (GERD), resolution of associated medical problems, and complications.
Methods: Patients were prospectively randomized into two groups: the AR group (resection starting 2 cm from the pylorus) and the AP group (resection at 5 cm from the pylorus). Follow-up evaluations included assessments of weight loss using percentage of excess weight loss (%EWL) and percentage of total weight loss (%TWL), gastric emptying, GERD symptoms, associated medical problem resolution, residual gastric volume, and complications.
Chemotherapy combined with immunotherapy in a patient with multiple primary gastric and rectal cancers with good prognosis: A case report.
Medicine (Baltimore)
November 2024
Department of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China.
Article Synopsis
- The article discusses the complexities of diagnosing multiple primary cancers and emphasizes the importance of genetic testing, specifically next-generation sequencing (NGS), in aiding this process.
- A 74-year-old male patient was diagnosed with rectal and gastric adenocarcinomas, and following comprehensive testing, he received personalized treatment that included chemotherapy and immunotherapy.
- The patient's successful outcome, with a complete remission of gastric lesions, illustrates the vital role of tailored treatment strategies based on genetic testing for managing multiple primary cancers.
Background And Aim: Endoscopic submucosal dissection (ESD) has become the treatment of choice for many superficial gastric neoplasms. Clinical outcomes are increasingly comparable between Japanese and Western series; however, data are lacking on the validity of risk stratification tools in Western cohorts. We aimed to evaluate clinical outcomes, explore risk stratification, and compare our data with published Western series.
View Article and Find Full Text PDFComparing ovarian reserve parameters after laparoscopic endometrioma resection in the follicular vs. luteal phase: a prospective cohort study.
Front Med (Lausanne)
October 2024
Department of Obstetrics and Gynecology, Maslak Hospital, Acibadem Mehmet Ali Aydinlar University, School of Medicine, İstanbul, Türkiye.
Objective: To evaluate whether performing laparoscopic endometrioma surgery in the follicular or luteal phase affects changes in ovarian reserve.
Methods: This prospective cohort study was conducted in a university-affiliated hospital. A total of 55 women who underwent unilateral laparoscopic endometrioma removal were included in the study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!